Rank/Rankl/opg: literature review

The discovery of the receptor activator of nuclear factor-kB (RANK)/RANK Ligand (RANKL)/osteoprotegerin (OPG) pathway contributed to the understanding of how bone formation and resorption were processed and regulated. RANKL and OPG are members of the tumor necrosis factor (TNF) and TNF receptor (TNF...

ver descrição completa

Detalhes bibliográficos
Autor principal: Silva, I (author)
Outros Autores: Branco, Jaime (author)
Formato: review
Idioma:eng
Publicado em: 2017
Assuntos:
Bone Formation
SYNOVIAL TISSUE
BREAST-TUMORS
Osteoprotegerin
OPG EXPRESSION
RECEPTOR ACTIVATOR
BONE-MINERAL DENSITY
RHEUMATOID-ARTHRITIS
RANK
KAPPA-B LIGAND
Osteoclast
OSTEOPROTEGERIN EXPRESSION
RANKL
POSTMENOPAUSAL WOMEN
OSTEOCLAST DIFFERENTIATION
Bone Formation.
Texto completo:http://hdl.handle.net/10362/22008
País:Portugal
Oai:oai:run.unl.pt:10362/22008

Texto Completo

http://hdl.handle.net/10362/22008

Registos relacionados